Recent Updates
Recently added Catalysts
ZLAB Positive Sentiment

Zai Lab to Present at 44th Annual J.P. Morgan Healthcare Conference

Monday, January 5, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Zai Lab Limited has announced its participation in the 44th Annual J.P. Morgan Healthcare Conference, scheduled for January 13, 2026. Senior management will present at 3:00 p.m. PST / 6:00 p.m. EST, with a live webcast available on the company's Investor Relations page. An archived replay will be accessible for 30 days post-event.
Price reaction · baseline $17.33 (2026-01-02 close) · hit pre-market · 1 other ZLAB headline(s) in the window, move may be shared
day 0 close
+4.4%

Market Sentiment Analysis

POSITIVE FACTORS

  • Zai Lab is participating in a prestigious healthcare conference.
  • The event provides an opportunity for Zai Lab to showcase its innovations.
  • Live webcast allows broader access to their presentation.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+104%
120-day peak, hindsight
Typical move
8.5%
average across 4 past catalysts
Cash runway
~164 mo
Low dilution risk
Lead asset
ZL-1211
Phase 1 · Advanced Solid Tumor

Full Press Release Details

SHANGHAI & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that members of the Company’s senior management team will participate in the 44thAnnual J.P. Morgan Healthcare Conference on Tuesday, January 13th, 2026, at 3:00 p.m. PST / 6:00 p.m. EST.
A live webcast of the presentation will be available on the Investor Relations page of Zai Lab’s website atir.zailaboratory.com/webcasts-presentations,and an archived replay will be available for up to 30 days following the completion of the event.
About Zai Lab
Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) is an innovative, research-based, commercial-stage biopharmaceutical company based in China and the United States. We are focused on discovering, developing, and commercializing innovative products that address medical conditions with significant unmet needs in the areas of oncology, immunology, neuroscience, and infectious disease. Our goal is to leverage our competencies and resources to positively impact human health.
For additional information about Zai Lab, please visitwww.zailaboratory.comor follow us atwww.twitter.com/ZaiLab_Global.

Frequently Asked Questions

When will Zai Lab present at the conference?

Zai Lab will present on January 13, 2026, at 3:00 p.m. PST.

How can I watch Zai Lab's presentation?

The presentation will be available via a live webcast on Zai Lab's Investor Relations page.

Will there be a replay of the presentation?

Yes, an archived replay will be available for 30 days after the event.

What is Zai Lab focused on?

Zai Lab is focused on developing innovative products in oncology, immunology, neuroscience, and infectious disease.

ShareAdd on Google
Tags: ZLAB Viatris Investor Conferences Healthcare Zai Lab J.P. Morgan Healthcare Conference biopharmaceutical NASDAQ: ZLAB healthcare
Last updated: Jan 5, 2026

Biotech snapshot

Cash runway
$661M liquidity · $4M/mo burn
~164 mo
Low dilution risk
Lead asset
ZL-1211Phase 1
Advanced Solid Tumor →

Catalyst track record

+104%
best trade around ZLAB's most recent catalyst

Peak hindsight return over a 120-day window, across 4 tracked FDA/PDUFA catalysts for ZLAB.

See every catalyst's timing & PoA →